Pharmaceuticals

Regen BioPharma recently filed a patent related to a mRNA cancer immunotherapeutic vaccine. Does the market growth potential make RGBP a good...

Here we take a look at Atai Life Sciences stock and examine whether the company's stock of alternative and psychedelic treatment candidates makes...

Eton Pharmaceuticals (NASDAQ: ETON) saw its stock price rise this morning following FDA approval for its epilepsy treatment. But is the stock a...

Pliant Therapeutics saw its share price more than double first thing on Monday after reporting positive feedback from trials of its pulmonary...

Veru Inc (NASDAQ: VERU) is buoyant following a strong showing from its COVID-19 treatment in a recent study, which excited investors having taken...

We break down and analyse the IPO of bioAffinity Technologies, a cancer testing specialist poised to join the NASDAQ index next week.

Tuesday's trending stocks include the likes of Yamana Gold (NYSE: AUY), Mullen Automotive (NASDAQ: MULN) and TherapeuticsMD (NASDAQ: TXMD).

Comera Life Sciences Holdings (NASDAQ: CMRA) $159m IPO. 

Bausch + Lomb is about to go public with an IPO, so we're taking a look at the stock to see if there's a clear case for investing.

Algernon Pharma (CSE: AGN, FRANKFURT: AGWO, OTCQB: AGNPF) plans to list on the NASDAQ Capital Market in an IPO. 

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) hopes to use gene therapy to cure pediatric diseases. RCKT stock has been rising this month. Is it a buy?

Sierra Oncology (NASDAQ: SRRA) shares leapt by more than 25% on Wednesday after a breakthrough in the firm's quest to commercialize a blood cancer...

A small recovery is expected on Monday morning after markets took a beating on Black Friday, with pharma continuing to rise and some travel stocks...

Pfizer's COVID-19 pill, vaccine and CFO resignation are making headlines this week. Does the news help boost its investment thesis?